[go: up one dir, main page]

SE9501285L - Förfarande för framställning av biologiskt aktiva proteiner - Google Patents

Förfarande för framställning av biologiskt aktiva proteiner

Info

Publication number
SE9501285L
SE9501285L SE9501285A SE9501285A SE9501285L SE 9501285 L SE9501285 L SE 9501285L SE 9501285 A SE9501285 A SE 9501285A SE 9501285 A SE9501285 A SE 9501285A SE 9501285 L SE9501285 L SE 9501285L
Authority
SE
Sweden
Prior art keywords
biologically active
active proteins
producing biologically
producing
proteins
Prior art date
Application number
SE9501285A
Other languages
English (en)
Other versions
SE9501285D0 (sv
Inventor
Johanna Ljung
Arne Holmgren
Fredrik Aaslund
Original Assignee
Johanna Ljung
Arne Holmgren
Fredrik Aaslund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johanna Ljung, Arne Holmgren, Fredrik Aaslund filed Critical Johanna Ljung
Priority to SE9501285A priority Critical patent/SE9501285L/sv
Publication of SE9501285D0 publication Critical patent/SE9501285D0/sv
Publication of SE9501285L publication Critical patent/SE9501285L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
SE9501285A 1995-04-06 1995-04-06 Förfarande för framställning av biologiskt aktiva proteiner SE9501285L (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE9501285A SE9501285L (sv) 1995-04-06 1995-04-06 Förfarande för framställning av biologiskt aktiva proteiner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501285A SE9501285L (sv) 1995-04-06 1995-04-06 Förfarande för framställning av biologiskt aktiva proteiner

Publications (2)

Publication Number Publication Date
SE9501285D0 SE9501285D0 (sv) 1995-04-06
SE9501285L true SE9501285L (sv) 1996-10-07

Family

ID=20397877

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9501285A SE9501285L (sv) 1995-04-06 1995-04-06 Förfarande för framställning av biologiskt aktiva proteiner

Country Status (1)

Country Link
SE (1) SE9501285L (sv)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8716240B2 (en) 2001-10-10 2014-05-06 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
US8791066B2 (en) 2004-07-13 2014-07-29 Novo Nordisk A/S Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1]
US8841439B2 (en) 2005-11-03 2014-09-23 Novo Nordisk A/S Nucleotide sugar purification using membranes
US8853161B2 (en) 2003-04-09 2014-10-07 Novo Nordisk A/S Glycopegylation methods and proteins/peptides produced by the methods
US8911967B2 (en) 2005-08-19 2014-12-16 Novo Nordisk A/S One pot desialylation and glycopegylation of therapeutic peptides
US8916360B2 (en) 2003-11-24 2014-12-23 Novo Nordisk A/S Glycopegylated erythropoietin
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US9050304B2 (en) 2007-04-03 2015-06-09 Ratiopharm Gmbh Methods of treatment using glycopegylated G-CSF
US9200049B2 (en) 2004-10-29 2015-12-01 Novo Nordisk A/S Remodeling and glycopegylation of fibroblast growth factor (FGF)
US9493499B2 (en) 2007-06-12 2016-11-15 Novo Nordisk A/S Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
JP4951527B2 (ja) 2005-01-10 2012-06-13 バイオジェネリックス アーゲー 糖ｐｅｇ化顆粒球コロニー刺激因子
US20070154992A1 (en) 2005-04-08 2007-07-05 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20080248959A1 (en) 2006-07-21 2008-10-09 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8716240B2 (en) 2001-10-10 2014-05-06 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
US8853161B2 (en) 2003-04-09 2014-10-07 Novo Nordisk A/S Glycopegylation methods and proteins/peptides produced by the methods
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US8916360B2 (en) 2003-11-24 2014-12-23 Novo Nordisk A/S Glycopegylated erythropoietin
US8791066B2 (en) 2004-07-13 2014-07-29 Novo Nordisk A/S Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1]
US9200049B2 (en) 2004-10-29 2015-12-01 Novo Nordisk A/S Remodeling and glycopegylation of fibroblast growth factor (FGF)
US10874714B2 (en) 2004-10-29 2020-12-29 89Bio Ltd. Method of treating fibroblast growth factor 21 (FGF-21) deficiency
US8911967B2 (en) 2005-08-19 2014-12-16 Novo Nordisk A/S One pot desialylation and glycopegylation of therapeutic peptides
US8841439B2 (en) 2005-11-03 2014-09-23 Novo Nordisk A/S Nucleotide sugar purification using membranes
US9050304B2 (en) 2007-04-03 2015-06-09 Ratiopharm Gmbh Methods of treatment using glycopegylated G-CSF
US9493499B2 (en) 2007-06-12 2016-11-15 Novo Nordisk A/S Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography

Also Published As

Publication number Publication date
SE9501285D0 (sv) 1995-04-06

Similar Documents

Publication Publication Date Title
DE69631903D1 (de) Diskreter gegenstromchromatographieprozess
NO982991D0 (no) Veksthormon-sekretagoguer
FI973281L (sv) Förfarande för framställning av vissa azacyklohexapeptider
FI960278A0 (sv) Förfarande för framställning av anatastitandioxid
DE69620107D1 (de) Kristallisationsverfahren
SE9501285L (sv) Förfarande för framställning av biologiskt aktiva proteiner
FI970258L (sv) Nytt förfarande för framställning av biologiskt aktivt protein
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
FI960193L (sv) Förfarande för desaktivering av mikroorganismer
EP0816510A4 (en) PROCESS FOR PRODUCING BIOLOGICALLY ACTIVE FUSED PROTEINS
FI973105A0 (sv) Förfarande för framställning av (4,10-diacetoxi-2alfa-bensoyloxi-5beta,20epoxi-1,7beta-dihydroxi-9-oxotax-11-en-13alfa-yl)-(2R,3S)-3-bensoylamino-3-fenyl-2-hydroxipropionaattrihydrat
FI973469L (sv) Förfarande för framställning av faktor IX ur biologiska källor
FI964229A0 (sv) Förfarande för framställning av doxorubicin
EE03440B1 (et) Bioloogilise toimega bensotiasolooni etaanamiinid ja nende valmistamise protsess
DE69735180D1 (de) Software-Aktualisierungsverfahren
FI945877L (sv) Förfarande för att producera protein C
KR970006251A (ko) 고단백 유기질 비료의 제조방법
FI973341A7 (sv) Förfarande för framställning av organosilaner
FI960790A0 (sv) Förfarande för framställning av fluorenbisfenol
FR2768308B1 (fr) Procede de fabrication d'un gel proteique
FI970039A0 (sv) Förfarande för framställning av 5-aryl-2,4-dialkyl-3H-1,2,3-triazol-3-tioner
FI950751A0 (sv) Förfarande för framställning av olefiner
FI101692B1 (sv) Förfarande för framställning av betongprodukter
FI97725B (sv) Förfarande för framställning av diltiazem
FI97745B (sv) Stödorgan och förfarande för tillverkning av stödorganet

Legal Events

Date Code Title Description
NAV Patent application has lapsed